Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Integrating Eastern and Western Medicine for Treatment of Granulomatous Mastitis
Published on: May 3, 2024
Clinical features and therapeutic management of idiopathic granulomatous mastitis
Maëlys Bretelle1, Catherine Miquel2, Nozha Mhamdi2
1Dermatology, Saint-Louis Hospital AP-HP, Paris, France.
Idiopathic granulomatous mastitis is a rare inflammatory breast disease affecting women aged 20-40 years, which can mimic infectious or neoplastic mastitis. This retrospective study at Saint-Louis Hospital, Paris, France, from 2010 to 2023, analysed histologically confirmed disease in 19 patients to refine its clinical and pathological features and evaluate treatments. Clinically, 89% of patients presented with one or more erythematous breast masses, often associated with abscesses, adenopathy, nipple retraction, oedema or fistulas. Histology showed large perilobular granulomas with polymorphic inflammation. Among the 18 treated patients, nonsteroidal anti-inflammatory drugs (NSAIDs) achieved complete remission in 50% (6/12), corticosteroids in 40% (2/5) and surveillance alone in 60% (5/8) of minimally symptomatic patients. Antibiotics led to partial remission in 23% but not complete remission. Surgery was not recommended because of its aesthetic impact. The median time to complete remission was 6 months, with three relapses. NSAIDs appeared to be an effective first-line treatment, while antibiotics showed limited efficacy. Further research is needed to standardize therapeutic protocols.
Idiopathic granulomatous mastitis is a rare inflammatory breast disease affecting women aged 20-40 years, which can mimic infectious or neoplastic mastitis. This retrospective study at Saint-Louis Hospital, Paris, France, from 2010 to 2023, analysed histologically confirmed disease in 19 patients to refine its clinical and pathological features and evaluate treatments. Clinically, 89% of patients presented with one or more erythematous breast masses, often associated with abscesses, adenopathy, nipple retraction, oedema or fistulas. Histology showed large perilobular granulomas with polymorphic inflammation. Among the 18 treated patients, nonsteroidal anti-inflammatory drugs (NSAIDs) achieved complete remission in 50% (6/12), corticosteroids in 40% (2/5) and surveillance alone in 60% (5/8) of minimally symptomatic patients. Antibiotics led to partial remission in 23% but not complete remission. Surgery was not recommended because of its aesthetic impact. The median time to complete remission was 6 months, with three relapses. NSAIDs appeared to be an effective first-line treatment, while antibiotics showed limited efficacy. Further research is needed to standardize therapeutic protocols.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Acute Pancreatitis II: Clinical Manifestations and Management
Tonsillitis II: Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

